Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion.

Jay, Cecilia; Ratcliff, Jeremy; Turtle, Lance; Goulder, Philip; Klenerman, Paul

Jay, Cecilia; Ratcliff, Jeremy; Turtle, Lance; Goulder, Philip; Klenerman, Paul.

Afiliação

Jay C; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Ratcliff J; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Turtle L; National Institute for Health and Care Research Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, Liverpool, United Kingdom.
Goulder P; Peter Medawar Building for Pathogen Research, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Klenerman P; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

Front Immunol ; 14: 1092910, 2023.

Article em En | MEDLINE | ID: mdl-36776841

Assuntos

COVID-19; Hepatite C; Humanos; SARS-CoV-2; Soroconversão; Imunidade Celular; Hepacivirus

Palavras-chave

SARS-CoV-2; T-cells; exposed; hepatitis C; seronegative

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / COVID-19 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google